Top Tweets for #corelearningpath
Our #CoreLearningPath is the essential course on obesity management. Available in English, Spanish, French and Portuguese, the course includes eight modules providing a comprehensive overview of how to diagnose, treat and manage obesity.
Learn more: https://t.co/WJIVI801O2

To obtain SCOPE Certification and be recognised internationally for your #obesity management skills, you'll need to complete the eight-module #CoreLearningPath and a selection of additional modules.
Learn more about our essential obesity course here: https://t.co/jwilkVOUB0

To obtain SCOPE Certification and be recognised internationally for your #obesity management skills, you'll need to complete the eight-module #CoreLearningPath and a selection of additional modules.
��️ Learn more about our essential obesity course here: https://t.co/jwilkW6vsy

.@DrRobertKushner is author of our e-learning module 'Complications of Obesity', available as part of the SCOPE #CoreLearningPath. The module takes an organ-based approach to reviewing the comorbidities associated with #obesity.
Find out more: https://t.co/TOn5jzaKW2
#CPD #CME

We have introduced a bundle including our #CoreLearningPath and our new course Childhood Obesity: From Diagnosis to Treatment, allowing users to purchase the two learning paths together at a reduced price.
Find out more: https://t.co/qvDGuQiCoj
All other modules remain free!

We have introduced a bundle including our #CoreLearningPath and our new course Childhood Obesity: From Diagnosis to Treatment, allowing users to purchase the two learning paths together at a reduced price.
Find out more: https://t.co/qvDGuQiCoj
All other modules remain free!

As of 31st January, the cost of our #CoreLearningPath will be increased to £80. Enrol today to purchase access at the current rate!
https://t.co/U98vGXfIJF
If you're at #UKCO, don't forget to complete the SCOPE sign in sheet at the registration desk to earn your 4 points towards SCOPE Certification!
There's also still time to drop by our exhibition stand and receive an exclusive discount on our #CoreLearningPath!

The @SCOPEObesity #CoreLearningPath is now available in Spanish, French and Portuguese!
Find out more about the essential #obesity course:
Español: https://t.co/yeYAc1T2ak
Français: https://t.co/1leIUNBGZj
Português: https://t.co/bVvqWMRD11
English: https://t.co/mmxLjSFm2p

Did you know that the #CoreLearningPath is now available in Spanish, French and Portuguese on the new SCOPE E-Learning platform?
Find out more using the links below...
Español: https://t.co/EI82pdCWQQ
Français: https://t.co/MiBNLl8C3l
Português: https://t.co/eQGtRVlxMd

Users with #CoreLearningPath access on the old platform have now been given access on the new platform. Those who have purchased, but not yet started the course should access it on the new platform. In-progress users should continue on the old platform, available until 1st April.
Are you attending #UKCO2018? Did you know attending the conference earns you 4 points towards your SCOPE Certification? Come to the World Obesity stand in the exhibition hall to learn more & for a discount on the #CoreLearningPath, with our very own Matt Pretty! @UK_ASO #obesity

.@SCOPEObesity 's #CoreLearningPath contains 8 modules on #obesity management authored by leading experts. Read more: https://t.co/4MfOMhkbjp

Prof Joseph Proietto authors our essential e-learning module 'Management of Obesity in Adults', available as part of the SCOPE #CoreLearningPath. Start your #obesity education today: https://t.co/Ud2Ag3ohlw

Dr Donna H. Ryan's e-learning module 'Obesity and Pharmacotherapy' considers the efficacy, safety and tolerability profiles of medications used to treat #obesity. The module is available as part of the SCOPE #CoreLearningPath: https://t.co/Ud2Ag3ohlw

Dr Donna H. Ryan's e-learning module 'Obesity and Pharmacotherapy' considers the efficacy, safety and tolerability profiles of medications used to treat #obesity. The module is available as part of the SCOPE #CoreLearningPath: https://t.co/Ud2Ag3ohlw

Dr Donna H. Ryan's e-learning module 'Obesity and Pharmacotherapy' considers the efficacy, safety and tolerability profiles of medications used to treat #obesity.
The module is available as part of the SCOPE #CoreLearningPath: https://t.co/Ud2Ag3ohlw

There are still a few discount cards for our #CoreLearningPath available at #YWM2018. Don't miss out - visit our stand (next to check-in) to collect one before they're all gone! @SCOPEObesity @ObesityAction

We'll be at #YWM2018 all day, right by the check-in desk. Come and try out our @SCOPEObesity modules and receive an exclusive discount on the #CoreLearningPath! @ObesityAction

Attending #YWM2018? Visit our booth at tonight's welcome reception to find out about World Obesity's work and receive a discount on the @SCOPEObesity #CoreLearningPath - exclusive to Your Weight Matters delegates! @YWMOAC @ObesityAction

Last Seen Hashtags on Sotwe
minichat #ometv
Seen from Turkey
minichat(*)(*)()* +filter:native_video
Seen from Turkey
bakire kız
Seen from Turkey
brosis(((())))
Seen from Poland
OneLoveEnElArea
Seen from United States
brookeshields
Seen from Turkey
dressingroom() + filter:videos
Seen from Turkey
monkeywins
Seen from United States
11maret
Seen from United States
pottachi
Seen from India
Most Popular Users

Elon Musk 
@elonmusk
241.7M followers

Barack Obama 
@barackobama
119M followers

Cristiano Ronaldo 
@cristiano
114.4M followers

Donald J. Trump 
@realdonaldtrump
111.9M followers

Narendra Modi 
@narendramodi
107.2M followers

Rihanna 
@rihanna
98.7M followers

NASA 
@nasa
92.4M followers

Justin Bieber 
@justinbieber
91.8M followers

KATY PERRY 
@katyperry
90M followers

Taylor Swift 
@taylorswift13
83.9M followers

Lady Gaga 
@ladygaga
75.4M followers

Virat Kohli 
@imvkohli
73.4M followers

Kim Kardashian 
@kimkardashian
70.9M followers

YouTube 
@youtube
68.8M followers

Neymar Jr 
@neymarjr
66.4M followers

Bill Gates 
@billgates
65.2M followers

Selena Gomez 
@selenagomez
63.1M followers

The Ellen Show
@theellenshow
62.3M followers

CNN 
@cnn
61.8M followers

X 
@x
60.7M followers

